Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma
- 1 May 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 6 (5) , 709-717
Abstract
Brain tumors are the second most common cancer in pediatric patients and the main cause from death of malignant tumors in this age group. High-grade or malignant glioma, among which anaplastic astrocytomas and glioblastoma are the most prevalent histotypes, represent 10% of pediatric brain tumors and, taken as a whole, are the second most frequent malignant histotype after medulloblastoma. Apart from complete excision followed by full-dose local radiotherapy, chemotherapy appears to provide some benefit to the final outcome. Different trials have explored the role of high-dose chemotherapy that, theoretically, could give an advantage to these patients by overcoming the blood-brain barrier, cell chemoresistance and inducing a wider number of responses. However, it is still doubtful if more responses translate into better outcome and it is not fully understood which patients can experience a true benefit from this treatment strategy. New protocols under evaluation include new agents with specific biological targets, multiple cycles of high-dose chemotherapy, and vaccination, as an immunotherapeutic approach.Keywords
This publication has 52 references indexed in Scilit:
- Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade gliomaNeuro-Oncology, 2005
- Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomasCancer, 2004
- Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumoursEuropean Journal of Cancer, 2002
- Preradiation chemotherapy for pediatric patients with high‐grade gliomaCancer, 2001
- Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumorsCancer, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adultsBone Marrow Transplantation, 1998
- Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89.Klinische Padiatrie, 1998
- Etoposide and thiotepa followed by ABMT (autologous bone marrow transplantation) in children and young adults with high-grade gliomasEuropean Journal of Cancer, 1997
- Is There a Role for High-Dose Chemotherapy with Stem Cell Rescue for Brain Stem Tumors of Childhood?Pediatric Neurosurgery, 1996